Novo Nordisk ADR · Health Care
Novo Nordisk (US-listed ADR) is the global leader in obesity and diabetes care, with Wegovy and Ozempic scaling worldwide. Competition is arriving, but supply ramp and oral obesity options keep growth elevated.
The AlphaInsight Score is a proprietary 0–100 composite of momentum, valuation, growth and safety factors. Research snapshot updated 2026-09-05.
NVO scores 82 out of 100 on the AlphaInsight composite— higher than roughly 88% of the 656 stocks in our research universe, and #5 among the 73 Health Care names we cover. The composite blends momentum, valuation, growth and safety factors.NVO's strongest pillar right now is growth (82/100), while valuation (52/100) is where the score gives ground.
On the fundamentals: a market capitalization of roughly $320 billion, a P/E ratio of 24.0, trailing EPS growth of 24.0%. The stock pays a dividend yield of about 1.9%.
From a risk and timing standpoint, the 14-day RSI sits at 55, a neutral zone between oversold and overbought; the current technical setup reads: Reclaiming the 50-day MA after a deep, sentiment-driven reset.
NVO operates in the Drug Manufacturers - General industry within the Health Care sector. The bull and bear cases below summarize where our research sees the balance of opportunity and risk in the stock right now.
GLP-1 supply scale and oral obesity pipeline extend a decade-long growth runway.
Drug-pricing politics could reprice the GLP-1 franchise faster than pipeline can replace it.
Novo Nordisk ADR scores 82/100 on the AlphaInsight Score — ranked #75 of 656 stocks in our research universe. It blends momentum (64/100), valuation (52/100), growth (82/100) and safety (78/100).
NVO currently carries an AlphaInsight Score of 82/100 in our research system. Subscribers receive daily entry, target and stop-loss levels whenever it appears in a slate.
Drug-pricing politics could reprice the GLP-1 franchise faster than pipeline can replace it.
Compare NVO head-to-head with LLY, PFE, ABBV on AlphaInsight Scores, valuation, growth and safety factors.
Subscribers get the complete thesis, risk factors and technical breakdown for NVOand 10 researched ideas every trading day.
Cancel anytime · Secure checkout
Ready-to-paste citation snippets for forums, Reddit, X or your own site.
[NVO stock research — AlphaInsight Score & technical signals](https://alphainsightai.net/stocks/NVO)<a href="https://alphainsightai.net/stocks/NVO">NVO stock research — AlphaInsight Score & technical signals</a>